Entry |
|
Name |
Sitravatinib (USAN/INN) |
Formula |
C33H29F2N5O4S
|
Exact mass |
629.1908
|
Mol weight |
629.68
|
Structure |

|
Simcomp |
|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
Remark |
|
Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EX Other protein kinase inhibitors
L01EX26 Sitravatinib
D11140 Sitravatinib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG03045 Sitravatinib
D11140 Sitravatinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
PDGFR family
PDGFR
D11140 Sitravatinib (USAN/INN)
VEGFR family
VEGFR1 (FLT1)
D11140 Sitravatinib (USAN/INN)
VEGFR2 (KDR)
D11140 Sitravatinib (USAN/INN)
VEGFR3 (FLT4)
D11140 Sitravatinib (USAN/INN)
MET family
MET
D11140 Sitravatinib (USAN/INN)
EPH family
EPHA1
D11140 Sitravatinib (USAN/INN)
EPHA2
D11140 Sitravatinib (USAN/INN)
EPHB1
D11140 Sitravatinib (USAN/INN)
EPHB2
D11140 Sitravatinib (USAN/INN)
EPHB4
D11140 Sitravatinib (USAN/INN)
AXL family
AXL
D11140 Sitravatinib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG03045 Sitravatinib
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 45
1 C8x C 18.1300 -13.0900
2 C8y C 18.1300 -14.4900
3 C8x C 16.9400 -15.2600
4 C8y C 15.6100 -14.4900
5 C8y C 15.6100 -13.0900
6 C8x C 16.9400 -12.3900
7 O2a O 14.3500 -12.3900
8 C8y C 13.1600 -13.0900
9 C8x C 13.1600 -14.4900
10 C8x C 11.9000 -15.2600
11 N5x N 10.7100 -14.4900
12 C8y C 10.7100 -13.0900
13 C8y C 11.9000 -12.3900
14 N1b N 19.3200 -15.2600
15 C5a C 20.5100 -14.4900
16 C1z C 21.7000 -15.2600
17 O5a O 20.5100 -13.0900
18 C5a C 22.8900 -14.4900
19 C1x C 22.4000 -16.4500
20 C1x C 21.0000 -16.4500
21 N1b N 24.0800 -15.2600
22 O5a O 22.8900 -13.0900
23 C8y C 25.2700 -14.4900
24 C8x C 25.2700 -13.0900
25 C8x C 26.4600 -12.3900
26 C8y C 27.7200 -13.0900
27 C8x C 27.7200 -14.4900
28 C8x C 26.5300 -15.2600
29 X F 28.9100 -12.3900
30 X F 14.3971 -15.1893
31 S2x S 11.6020 -11.0419
32 C8y C 10.2278 -10.9088
33 C8x C 9.6765 -12.1745
34 C8y C 9.5209 -9.7071
35 C8x C 10.2010 -8.5068
36 C8x C 9.4913 -7.3000
37 C8y C 8.0913 -7.3113
38 C8x C 7.4112 -8.5116
39 N5x N 8.1209 -9.7183
40 C1b C 7.3753 -6.0945
41 N1b N 5.9501 -6.1064
42 C1b C 5.2327 -4.8877
43 C1b C 3.8500 -4.8995
44 O2a O 3.1399 -3.6934
45 C1a C 1.7500 -3.7054
BOND 50
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 2 14 1
16 14 15 1
17 15 16 1
18 15 17 2
19 16 18 1
20 19 20 1
21 20 16 1
22 16 19 1
23 18 21 1
24 18 22 2
25 21 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 23 28 1
32 26 29 1
33 4 30 1
34 13 31 1
35 31 32 1
36 32 33 2
37 12 33 1
38 32 34 1
39 34 35 2
40 35 36 1
41 36 37 2
42 37 38 1
43 38 39 2
44 34 39 1
45 37 40 1
46 40 41 1
47 41 42 1
48 42 43 1
49 43 44 1
50 44 45 1
|